Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Canadian Journal of Anesthesia/Journal canadien d'anesthésie
Erschienen in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie 2/2017

28.07.2016 | Review Article/Brief Review

Non-opioid anesthetic drug abuse among anesthesia care providers: a narrative review

verfasst von: Alix Zuleta-Alarcón, MD, John C. Coffman, MD, Suren Soghomonyan, MD, PhD, Thomas J. Papadimos, MD, Sergio D. Bergese, MD, Kenneth R. Moran, MD

Erschienen in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The objective of this narrative review is to provide an overview of the problem of non-opioid anesthetic drug abuse among anesthesia care providers (ACPs) and to describe current approaches to screening, therapy, and rehabilitation of ACPs suffering from non-opioid anesthetic drug abuse.

Source

We first performed a search of all literature available on PubMed prior to April 11, 2016. The search was limited to articles published in Spanish and English, and the following key words were used: anesthesiology, anesthesia personnel, AND substance-related disorders. We also searched Ovid MEDLINE® databases from 1946-April 11, 2016 using the following search terms: anesthesiology OR anesthesia, OR nurse anesthetist OR anesthesia care provider OR perioperative nursing AND substance-related disorders.

Principal findings

Despite an increased awareness of drug abuse among ACPs and improvements in preventive measures, the problem of non-opioid anesthetic drug abuse remains significant. While opioids are the most commonly abused anesthesia medications among ACPs, the abuse of non-opioid anesthetics is a significant cause of morbidity, mortality, and professional demise.

Conclusion

Early detection, effective therapy, and long-term follow-up help ACPs cope more effectively with the problem and, when possible, resume their professional activities. There is insufficient evidence to determine the ability of ACPs to return safely to anesthesia practice after rehabilitation, though awareness of the issue and ongoing treatment are necessary to minimize patient risk from potentially related clinical errors.
Literatur
1.
Booth JV, Grossman D, Moore J, et al. Substance abuse among physicians: a survey of academic anesthesiology programs. Anesth Analg 2002; 95: 1024-30.PubMed
2.
Domino KB, Hornbein TF, Polissar NL, et al. Risk factors for relapse in health care professionals with substance use disorders. JAMA 2005; 293: 1453-60.CrossRefPubMed
3.
4.
Hughes PH, Conard SE, Baldwin DC Jr, Storr CL, Sheehan DV. Resident physician substance use in the United States. JAMA 1991; 265: 2069-73.CrossRefPubMed
5.
6.
Lutsky I, Hopwood M, Abram SE, Jacobson GR, Haddox JD, Kampine JP. Psychoactive substance use among American anesthesiologists: a 30-year retrospective study. Can J Anaesth 1993; 40: 915-21.CrossRefPubMed
7.
Merlo LJ, Singhakant S, Cummings SM, Cottler LB. Reasons for misuse of prescription medication among physicians undergoing monitoring by a physician health program. J Addict Med 2013; 7: 349-53.CrossRefPubMedPubMedCentral
8.
Bryson EO, Hamza H. The drug seeking anesthesia care provider. Int Anesthesiol Clin 2011; 49: 157-71.CrossRefPubMed
9.
Warner DO, Berge K, Sun H, Harman A, Hanson A, Schroeder DR. Substance use disorder among anesthesiology residents, 1975-2009. JAMA 2013; 310: 2289-96.CrossRefPubMedPubMedCentral
10.
Talbott GD, Gallegos KV, Wilson PO, Porter TL, The Medical Association of Georgia’s Impaired Physicians Program. Review of the first 1000 physicians: analysis of specialty. JAMA 1987; 257: 2927-30.CrossRefPubMed
11.
Gallegos KV, Browne CH, Veit FW, Talbott GD. Addiction in anesthesiologists: drug access and patterns of substance abuse. QRB Qual Rev Bull 1988; 14: 116-22.CrossRefPubMed
12.
DuPont RL, McLellan AT, White WL, Merlo LJ, Gold MS. Setting the standard for recovery: Physicians’ Health Programs. J Subst Abuse Treat 2009; 36: 159-71.CrossRefPubMed
13.
Fry RA. Substance abuse by anaesthetists in Australia and New Zealand. Anaesth Intensive Care 2005; 33: 248-55.PubMed
14.
Fry RA, Fry LE, Castanelli DJ. A retrospective survey of substance abuse in anaesthetists in Australia and New Zealand from 2004 to 2013. Anaesth Intensive Care 2015; 43: 111-7.PubMed
15.
16.
Merlo LJ, Goldberger BA, Kolodner D, Fitzgerald K, Gold MS. Fentanyl and propofol exposure in the operating room: sensitization hypotheses and further data. J Addict Dis 2008; 27: 67-76.CrossRefPubMed
17.
McDonnell NJ, Kaye RM, Hood S, Shrivastava P, Khursandi DC. Mental health and welfare in Australian anaesthetists. Anaesth Intensive Care 2013; 41: 641-7.PubMed
18.
McAuliffe PF, Gold MS, Bajpai L, et al. Second-hand exposure to aerosolized intravenous anesthetics propofol and fentanyl may cause sensitization and subsequent opiate addiction among anesthesiologists and surgeons. Med Hypotheses 2006; 66: 874-82.CrossRefPubMed
19.
Gold MS, Melker RJ, Dennis DM, et al. Fentanyl abuse and dependence: further evidence for second hand exposure hypothesis. J Addict Dis 2006; 25: 15-21.CrossRefPubMed
20.
21.
Yeh HH, Tian M, Hinz R, et al. Imaging epigenetic regulation by histone deacetylases in the brain using PET/MRI with (1)(8)F-FAHA. Neuroimage 2013; 64: 630-9.CrossRefPubMed
22.
Garcia-Guasch R, Roige J, Padros J. Substance abuse in anaesthetists. Curr Opin Anaesthesiol 2012; 25: 204-9.CrossRefPubMed
23.
Passik SD, Hays L, Eisner N, Kirsh KL. Psychiatric and pain characteristics of prescription drug abusers entering drug rehabilitation. J Pain Palliat Care Pharmacother 2006; 20: 5-13.CrossRefPubMed
24.
Schaeffer T. Abuse-deterrent formulations, an evolving technology against the abuse and misuse of opioid analgesics. J Med Toxicol 2012; 8: 400-7.CrossRefPubMedPubMedCentral
25.
Earley PH, Finver T. Addiction to propofol: a study of 22 treatment cases. J Addict Med 2013; 7: 169-76.CrossRefPubMed
26.
27.
Bonnet U, Scherbaum N. Craving dominates propofol addiction of an affected physician. J Psychoactive Drugs 2012; 44: 186-90.CrossRefPubMed
28.
Wischmeyer PE, Johnson BR, Wilson JE, et al. A survey of propofol abuse in academic anesthesia programs. Anesth Analg 2007; 105: 1066-71.CrossRefPubMed
29.
Follette JW, Farley WJ. Anesthesiologist addicted to propofol. Anesthesiology 1992; 77: 817-8.CrossRefPubMed
30.
Wilson C, Canning P, Caravati EM. The abuse potential of propofol. Clin Toxicol (Phila) 2010; 48: 165-70.CrossRef
31.
Shrivastava PP, Zuccherelli L. Can we all survive propofol? Anaesth Intensive Care 2015; 43: 9-11.PubMed
32.
Bonnet U, Harkener J, Scherbaum N. A case report of propofol dependence in a physician. J Psychoactive Drugs 2008; 40: 215-7.CrossRefPubMed
33.
Weetman DB, Mascardo LA, Ross MB, Abramowitz PW. Propofol as a drug of diversion. Am J Health Syst Pharm 2004; 61: 1185-6.PubMed
34.
Ward CF, Ward GC, Saidman LJ. Drug abuse in anesthesia training programs. A survey: 1970 through 1980. JAMA 1983; 250: 922-5.CrossRefPubMed
35.
Wilson JE, Kiselanova N, Stevens Q, et al. A survey of inhalational anaesthetic abuse in anaesthesia training programmes. Anaesthesia 2008; 63: 616-20.CrossRefPubMed
36.
Musshoff F, Junker H, Madea B. An unusual case of driving under the influence of enflurane. Forensic Sci Int 2002; 128: 187-9.CrossRefPubMed
37.
Pavlic M, Haidekker A, Grubwieser P, Rabl W. Fatal accident caused by isoflurane abuse. Int J Legal Med 2002; 116: 357-60.CrossRefPubMed
38.
Campagna JA, Miller KW, Forman SA. Mechanisms of actions of inhaled anesthetics. N Engl J Med 2003; 348: 2110-24.CrossRefPubMed
39.
Beckman NJ, Zacny JP, Walker DJ. Within-subject comparison of the subjective and psychomotor effects of a gaseous anesthetic and two volatile anesthetics in healthy volunteers. Drug Alcohol Depend 2006; 81: 89-95.CrossRefPubMed
40.
Yamakura T, Harris RA. Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels. Comparison with isoflurane and ethanol. Anesthesiology 2000; 93: 1095-101.CrossRefPubMed
41.
Moore NN, Bostwick JM. Ketamine dependence in anesthesia providers. Psychosomatics 1999; 40: 356-9.CrossRefPubMed
42.
43.
Bozimowski G, Groh C, Rouen P, Dosch M. The prevalence and patterns of substance abuse among nurse anesthesia students. AANA J 2014; 82: 277-83.PubMed
44.
Menk EJ, Baumgarten RK, Kingsley CP, Culling RD, Middaugh R. Success of reentry into anesthesiology training programs by residents with a history of substance abuse. JAMA 1990; 263: 3060-2.CrossRefPubMed
45.
Hamza H, Bryson EO. Exposure of anesthesia providers in recovery from substance abuse to potential triggering agents. J Clin Anesth 2011; 23: 552-7.CrossRefPubMed
46.
Mion G, Villevieille T. Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings). CNS Neurosci Ther 2013; 19: 370-80.CrossRefPubMed
47.
Cheong SH, Lee KM, Lim SH, et al. Brief report: the effect of suggestion on unpleasant dreams induced by ketamine administration. Anesth Analg 2011; 112: 1082-5.CrossRefPubMed
48.
Moretti RJ, Hassan SZ, Goodman LI, Meltzer HY. Comparison of ketamine and thiopental in healthy volunteers: effects on mental status, mood, and personality. Anesth Analg 1984; 63: 1087-96.CrossRefPubMed
49.
Hocking G, Cousins MJ. Ketamine in chronic pain management: an evidence-based review. Anesth Analg 2003; 97: 1730-9.CrossRefPubMed
50.
Morgan CJ, Curran HV, Independent Scientific Committee on Drugs. Ketamine use: a review. Addiction 2012; 107: 27-38.CrossRefPubMed
51.
Ng SH, Tse ML, Ng HW, Lau FL. Emergency department presentation of ketamine abusers in Hong Kong: a review of 233 cases. Hong Kong Med J 2010; 16: 6-11.PubMed
52.
Morgan CJ, Muetzelfeldt L, Curran HV. Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study. Addiction 2010; 105: 121-33.CrossRefPubMed
53.
54.
Featherstone RE, Liang Y, Saunders JA, Tatard-Leitman VM, Ehrlichman RS, Siegel SJ. Subchronic ketamine treatment leads to permanent changes in EEG, cognition and the astrocytic glutamate transporter EAAT2 in mice. Neurobiol Dis 2012; 47: 338-46.CrossRefPubMed
55.
Hollister LE, Motzenbecker FP, Degan RO. Withdrawal reactions to chlordiazepoxide (‘Librium’). Psychopharmacologia 1961; 2: 63-9.CrossRefPubMed
56.
Lutsky I, Hopwood M, Abram SE, Cerletty JM, Hoffman RG, Kampine JP. Use of psychoactive substances in three medical specialties: anaesthesia, medicine and surgery. Can J Anaesth 1994; 41: 561-7.CrossRefPubMed
57.
Fry RA, Fry LE, Weeks A. Substance use disorder amongst Australian and New Zealand anaesthetic trainees: an analysis of 30 years of data. Anaesth Intensive Care 2015; 43: 530.PubMed
58.
Bell DM, McDonough JP, Ellison JS, Fitzhugh EC. Controlled drug misuse by Certified Registered Nurse Anesthetists. AANA J 1999; 67: 133-40.PubMed
59.
Luck S, Hedrick J. The alarming trend of substance abuse in anesthesia providers. J Perianesth Nurs 2004; 19: 308-11.CrossRefPubMed
60.
Tetzlaff J, Collins GB, Brown DL, Leak BC, Pollock G, Popa D. A strategy to prevent substance abuse in an academic anesthesiology department. J Clin Anesth 2010; 22: 143-50.CrossRefPubMed
61.
Rose GL, Brown RE Jr. The impaired anesthesiologist: not just about drugs and alcohol anymore. J Clin Anesth 2010; 22: 379-84.CrossRefPubMed
62.
May JA, Warltier DC, Pagel PS. Attitudes of anesthesiologists about addiction and its treatment: a survey of Illinois and Wisconsin members of the American Society of Anesthesiologists. J Clin Anesth 2002; 14: 284-9.CrossRefPubMed
63.
Berge KH, Dillon KR, Sikkink KM, Taylor TK, Lanier WL. Diversion of drugs within health care facilities, a multiple-victim crime: patterns of diversion, scope, consequences, detection, and prevention. Mayo Clin Proc 2012; 87: 674-82.CrossRefPubMedPubMedCentral
64.
Epstein RH, Gratch DM, McNulty S, Grunwald Z. Validation of a system to detect scheduled drug diversion by anesthesia care providers. Anesth Analg 2011; 113: 160-4.CrossRefPubMed
65.
Epstein RH, Gratch DM, Grunwald Z. Development of a scheduled drug diversion surveillance system based on an analysis of atypical drug transactions. Anesth Analg 2007; 105: 1053-60.CrossRefPubMed
66.
Devine B, Gutierrez K, Rogers R. Drug diversion by anesthesiologists: identification through intensive auditing. Am J Health Syst Pharm 2012. DOI:10.​2146/​ajhp120010.PubMed
67.
Klein RL, Stevens WC, Kingston HG. Controlled substance dispensing and accountability in United States anesthesiology residency programs. Anesthesiology 1992; 77: 806-11.CrossRefPubMed
68.
Berge KH, Seppala MD, Lanier WL. The anesthesiology community’s approach to opioid- and anesthetic-abusing personnel: time to change course. Anesthesiology 2008; 109: 762-4.CrossRefPubMed
69.
Fitzsimons MG, Ishizawa Y, Baker KH. Drug testing physicians for substances of abuse: case report of a false-positive result. J Clin Anesth 2013; 25: 669-71.CrossRefPubMed
70.
Fitzsimons MG, Baker KH, Lowenstein E, Zapol WM. Random drug testing to reduce the incidence of addiction in anesthesia residents: preliminary results from one program. Anesth Analg 2008; 107: 630-5.CrossRefPubMed
71.
72.
Kintz P, Villain M, Dumestre V, Cirimele V. Evidence of addiction by anesthesiologists as documented by hair analysis. Forensic Sci Int 2005; 153: 81-4.CrossRefPubMed
73.
Brock MF, Roy RC. Random urine drug testing. Anesth Analg 2009; 108: 676; author reply 676-7.
74.
Spiegelman WG, Saunders L, Mazze RI. Addiction and anesthesiology. Anesthesiology 1984; 60: 335-41.CrossRefPubMed
75.
Skipper GE, Campbell MD, Dupont RL. Anesthesiologists with substance use disorders: a 5-year outcome study from 16 state physician health programs. Anesth Analg 2009; 109: 891-6.CrossRefPubMed
76.
Monroe T, Hamza H, Stocks G, Scimeca PD, Cowan R. The misuse and abuse of propofol. Subst Use Misuse 2011; 46: 1199-205.CrossRefPubMed
77.
Oreskovich MR, Caldeiro RM. Anesthesiologists recovering from chemical dependency: can they safely return to the operating room? Mayo Clin Proc 2009; 84: 576-80.CrossRefPubMedPubMedCentral
78.
Palhares-Alves HN, Vieira DL, Laranjeira RR, Vieira JE, Nogueira-Martins LA. Clinical and demographic profile of anesthesiologists using alcohol and other drugs under treatment in a pioneering program in Brazil. Rev Bras Anestesiol 2012; 62: 356-64.CrossRefPubMed
79.
Sivarajan M, Posner KL, Caplan RA, Gild WM, Cheney FW. Substance abuse among anesthesiologists. Anesthesiology 1994; 80: 704.CrossRefPubMed
80.
Berry CB, Crome IB, Plant M, Plant M. Substance misuse amongst anaesthetists in the United Kingdom and Ireland. The results of a study commissioned by the Association of Anaesthetists of Great Britain and Ireland. Anaesthesia 2000; 55: 946-52.CrossRefPubMed
81.
Gravenstein JS, Kory WP, Marks RG. Drug abuse by anesthesia personnel. Anesth Analg 1983; 62: 467-72.PubMed
82.
Weeks AM, Buckland MR, Morgan EB, Myles PS. Chemical dependence in anaesthetic registrars in Australia and New Zealand. Anaesth Intensive Care 1993; 21: 151-5.PubMed
83.
Saunders D. Substance abuse and dependence in anaesthetists. Best Pract Res Clin Anaesthesiol 2006; 20: 637-43.CrossRefPubMed
84.
Alexander BH, Checkoway H, Nagahama SI, Domino KB. Cause-specific mortality risks of anesthesiologists. Anesthesiology 2000; 93: 922-30.CrossRefPubMed
85.
86.
Warner DO, Berge K, Sun H, Harman A, Hanson A, Schroeder DR. Risk and outcomes of substance use disorder among anesthesiology residents: a matched cohort analysis. Anesthesiology 2015; 123: 929-36.CrossRefPubMedPubMedCentral
87.
Collins GB, McAllister MS, Jensen M, Gooden TA. Chemical dependency treatment outcomes of residents in anesthesiology: results of a survey. Anesth Analg 2005; 101: 1457-62.CrossRefPubMed
88.
Bryson EO, Levine A. One approach to the return to residency for anesthesia residents recovering from opioid addiction. J Clin Anesth 2008; 20: 397-400.CrossRefPubMed
89.
Bryson EO. Should anesthesia residents with a history of substance abuse be allowed to continue training in clinical anesthesia? The results of a survey of anesthesia residency program directors. J Clin Anesth 2009; 21: 508-13.CrossRefPubMed
90.
McClintock JC, Gravlee GP. Predicting success on the certification examinations of the American Board of Anesthesiology. Anesthesiology 2010; 112: 212-9.CrossRefPubMed
91.
Metadaten
Titel
Non-opioid anesthetic drug abuse among anesthesia care providers: a narrative review
verfasst von
Alix Zuleta-Alarcón, MD
John C. Coffman, MD
Suren Soghomonyan, MD, PhD
Thomas J. Papadimos, MD
Sergio D. Bergese, MD
Kenneth R. Moran, MD
Publikationsdatum
28.07.2016
Verlag
Springer US
Erschienen in
Canadian Journal of Anesthesia/Journal canadien d'anesthésie / Ausgabe 2/2017
Print ISSN: 0832-610X
Elektronische ISSN: 1496-8975
DOI
https://doi.org/10.1007/s12630-016-0698-7

Weitere Artikel der Ausgabe 2/2017

Canadian Journal of Anesthesia/Journal canadien d'anesthésie 2/2017 Zur Ausgabe

Review Article/Brief Review

Self-care as a professional imperative: physician burnout, depression, and suicide

Review Article/Brief Review

Disruptive behaviour in the perioperative setting: a contemporary review

Special Article

Anesthesiology Resident Wellness Program at the University of Saskatchewan: curriculum content and delivery

Special Article

The identification and management of substance use disorders in anesthesiologists

Editorials

The physician at risk: disruptive behaviour, burnout, addiction, and suicide

Review Article/Brief Review

Professionalism in anesthesia

Neu im Fachgebiet AINS

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

Delir bei kritisch Kranken – Antipsychotika versus Placebo

16.05.2024 Delir Nachrichten

Um die Langzeitfolgen eines Delirs bei kritisch Kranken zu mildern, wird vielerorts auf eine Akuttherapie mit Antipsychotika gesetzt. Eine US-amerikanische Forschungsgruppe äußert jetzt erhebliche Vorbehalte gegen dieses Vorgehen. Denn es gibt neue Daten zum Langzeiteffekt von Haloperidol bzw. Ziprasidon versus Placebo.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren
Bildnachweise